Advanced Orthopedic Technologies, Implants and Regenerative Products

Report Code: HLC052B

Publish Date: Jan 2011

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The total market for advanced orthopedic technology and products was estimated to exceed $28 billion in 2010. New technologies and an increasingly older population are two of the major driving forces within the market. By 2015, the advanced orthopedic technology and product market is likely to reach $32.4 billion, with a compound annual growth rate (CAGR) from 2010 to 2015 of 2.7%.

SCOPE OF THE REPORT

This study will be a helpful business tool providing a thorough evaluation of the advanced orthopedic market. Its geographic scope is global with special emphasis on the United States and the European Union. The report identifies markets in three general segments:

  • Bone repair and regenerative products
  • Cartilage and soft tissue repair and regenerative products
  • Joint replacement, implants, and regenerative products.

Each market segment provides detailed information based on product categories, product use, forecasts, and competitive analyses.

Advanced orthopedics deals with those products involving new techniques and therapies. They provide a significant patient outcome over traditional methods, as well as improving healing and lowering overall care costs. These products incorporate biotechnological advancements and improved methods for dealing with orthopedic injuries and conditions.

Products in this study are considered to be at the forefront of orthopedic device technology. Products not considered advanced include external bracing, slings, casting materials etc. Those classified by industry experts as advanced orthopedic products include: human bone products and materials, bone growth stimulators, synthetic bone replacements, cartilage and soft tissue fixation systems, biologics/biomaterials, complex joint replacement devices, spine devices, and joint fluid replacements.

ABOUT THE AUTHOR

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices, and emerging healthcare technologies. Ms. Elder has more than 15 years experience in the healthcare industry, specializing in market research for the past 12 years. This experience has given her substantial insights into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Advanced Orthopedic Technologies, Implants and Regenerative Products202Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY4Free
Chapter- 3: INDUSTRY OVERVIEW17Free
Chapter- 4: ISSUES AFFECTING THE MARKET47Free
Chapter- 5: TECHNOLOGY22Free
Chapter- 6: BONE REPAIR AND REGENERATIVE PRODUCTS26Free
Chapter- 7: CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS 17Free
Chapter- 8: JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS 36Free
Chapter- 9: MARKET SUMMARY8Free
Chapter- 10: C. CRAMER & CO. GMBH13Free
Chapter- 11: APPENDIX: LEADING PRODUCT MANUFACTURERS8Free
Published - May-2007| Analyst - Melissa Elder| Code - HLC052A

Report Highlights

  • The total market for advanced orthopedic technology and products was estimated to exceed $17.5 billion in 2006, up 11.7% from $15.7 billion the previous year (2005). By 2012, the advanced orthopedic technology and product market is likely to reach $31.9 billion, with average growth estimated at 10.3%.
  • Worldwide, the bone repair and regenerative product market has increased at a rate of 19% to 22% annually over the past several years. In 2006, the market experienced a 22% increase over the $910 million in 2005 to reach $1.1 billion.
  • Worldwide, the total joint replacement, implant and regenerative product markets generated approximately $15.8 billion in 2006, an increase of 11.4% over $11.2 billion estimated for 2005.

Related Reports

Recent Reports

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - HLC071E

The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Advanced Orthopedic Technologies, Implants and Regenerative Products
Customize Report